Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | 57,758 | 89,481 | 34.57% | +31,723 |
| RAPT Therapeutics, Inc. | 1,562,500 | 1,562,500 | 0 | 12,500 | 40,297 | 15.57% | +27,797 |
| Verastem, Inc.(VSTM) | 1,276,520 | 2,615,120 | +1,338,600 | 5,298 | 23,092 | 8.92% | +17,794 |
| Centessa Pharmaceuticals plc | 1,253,379 | 1,314,019 | +60,640 | 16,469 | 31,865 | 12.31% | +15,396 |
| Denali Therapeutics Inc.(DNLI) | 0 | 1,000,000 | +1,000,000 | 0 | 14,520 | 5.61% | +14,520 |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,731,233 | 1,731,233 | 0 | 6,925 | 12,759 | 4.93% | +5,834 |
| ALUMIS INC. | 4,247,670 | 4,247,670 | 0 | 12,743 | 16,948 | 6.55% | +4,205 |
| Kymera Therapeutics, Inc.(KYMR) | 146,332 | 146,332 | 0 | 6,386 | 8,282 | 3.20% | +1,896 |
| CASI Pharmaceuticals, Inc.(CASIF) | 787,121 | 979,956 | +192,835 | 929 | 1,627 | 0.63% | +698 |
| Avidity Biosciences, Inc. | 40,000 | 40,000 | 0 | 1,136 | 1,743 | 0.67% | +607 |
| Viridian Therapeutics, Inc(VRDN) | 1,974 | 0 | -1,974 | 28 | 0 | — | -28 |
| Hinge Health, Inc.(HNGE) | 135,000 | 135,000 | 0 | 6,986 | 6,626 | 2.56% | -360 |
| Spyre Therapeutics Inc(SYRE) | 70,000 | 0 | -70,000 | 1,048 | 0 | — | -1,048 |
| Akero Therapeutics, Inc. | 244,900 | 244,900 | 0 | 13,068 | 11,628 | 4.49% | -1,440 |
| Ideaya Biosciences Inc(IDYA) | 144,468 | 0 | -144,468 | 3,037 | 0 | — | -3,037 |
| Allogene Therapeutics Inc | 2,875,357 | 0 | -2,875,357 | 3,249 | 0 | — | -3,249 |
| Structure Therapeutics Inc | 210,000 | 0 | -210,000 | 4,355 | 0 | — | -4,355 |
| Cullinan Therapeutics Inc(CGEM) | 594,025 | 0 | -594,025 | 4,473 | 0 | — | -4,473 |
| Xenon Pharmaceuticals Inc(XENE) | 160,000 | 0 | -160,000 | 5,008 | 0 | — | -5,008 |
| Edgewise Therapeutics Inc(EWTX) | 585,000 | 0 | -585,000 | 7,669 | 0 | — | -7,669 |
| Bicara Therapeutics Inc | 949,260 | 0 | -949,260 | 8,819 | 0 | — | -8,819 |